- Home
- MPV vs SCPH Comparison
MPV vs SCPH Comparison
Compare MPV & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPV
- SCPH
- Stock Information
- Founded
- MPV 1988
- SCPH 2013
- Country
- MPV United States
- SCPH United States
- Employees
- MPV N/A
- SCPH N/A
- Industry
- MPV Finance Companies
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- MPV Finance
- SCPH Health Care
- Exchange
- MPV Nasdaq
- SCPH Nasdaq
- Market Cap
- MPV 170.6M
- SCPH 163.3M
- IPO Year
- MPV N/A
- SCPH 2017
- Fundamental
- Price
- MPV $16.23
- SCPH $5.11
- Analyst Decision
- MPV
- SCPH Strong Buy
- Analyst Count
- MPV 0
- SCPH 2
- Target Price
- MPV N/A
- SCPH $19.00
- AVG Volume (30 Days)
- MPV 25.2K
- SCPH 257.6K
- Earning Date
- MPV 01-01-0001
- SCPH 08-14-2024
- Dividend Yield
- MPV 8.71%
- SCPH N/A
- EPS Growth
- MPV N/A
- SCPH N/A
- EPS
- MPV 1.71
- SCPH N/A
- Revenue
- MPV N/A
- SCPH $24,048,000.00
- Revenue This Year
- MPV N/A
- SCPH $195.62
- Revenue Next Year
- MPV N/A
- SCPH $145.07
- P/E Ratio
- MPV $9.35
- SCPH N/A
- Revenue Growth
- MPV N/A
- SCPH 549.77
- 52 Week Low
- MPV $11.18
- SCPH $3.24
- 52 Week High
- MPV $16.42
- SCPH $7.55
- Technical
- Relative Strength Index (RSI)
- MPV 56.53
- SCPH 53.76
- Support Level
- MPV $15.88
- SCPH $4.97
- Resistance Level
- MPV $16.38
- SCPH $5.30
- Average True Range (ATR)
- MPV 0.29
- SCPH 0.26
- MACD
- MPV 0.04
- SCPH -0.02
- Stochastic Oscillator
- MPV 72.86
- SCPH 39.06
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.